Association between Periodontal Disease and Comorbidities in Saudi’s Eastern Province

Table 5

Association between alveolar bone loss and HTN with other comorbidities.

Factor		Model 1; HTN		Model 2; HTN & hyperlipidemia		Model 3; HTN & CHD
		(95% CI)	value	(95% CI)	value	(95% CI)	value
Age	>50	2.17 (0.29, 4.12)	0.03	2.72 (0.85, 4.60)	0.005	2.65 (0.79, 4.50)	0.005
	25-50	1.48 (0.05, 2.90)	0.04	1.59 (0.15, 3.02)	0.03	1.63 (0.18, 3.03)	0.02
	18-<25	Reference		Reference		Reference
Gender	Males	0.59 (-0.83, 2.01)	0.41	0.71 (-0.73, 2.15)	0.34	0.59 (-0.85, 2.02)	0.42
	Females	Reference		Reference		Reference
Nationality	Saudi	0.19 (-0.85, 1.23)	0.72	0.08 (-0.97, 1.13)	0.88	0.18 (-0.86, 1.23)	0.73
	Non-Saudi	Reference		Reference		Reference
Smoking	Yes	1.44 (-0.39, 2.91)	0.05	1.30 (-0.20, 2.80)	0.09	1.32 (-0.16, 2.79)	0.08
	No	Reference		Reference		Reference
Number of missing teeth	>5	0.75 (-1.61, 2.11)	0.79	0.68 (-1.47, 2.29)	0.67	0.42 (-1.44, 2.29)	0.65
	3-5	1.65 (0.28, 2.62)	0.02	1.63 (0.09, 3.58)	0.03	1.81 (0.69, 3.61)	0.02
	0-2	Reference		Reference		Reference
Comorbidity	Yes	1.67 (0.15, 3.18)	0.03	0.31 (-2.40, 3.03)	0.82	2.96 (-1.05, 6.96)	0.15
	No	Reference		Reference		Reference

Model 1: effect of HTN on amount of bone loss with other confounders controlled, adjusted , value < 0.001. Model 2: effect of HTN and hyperlipidemia on bone loss with other confounders controlled, adjusted , value < 0.001. Model 3: effect of HTN and CHD on bone loss with other confounders controlled, adjusted , value < 0.001.